Patent Law Community | LexisNexis
Featured Content
  • Add content to My Page

    Select any content type from the list, once selected it will be automatically added to your 'My Page'.


    You are not logged in. Please Login to add content to your community page

  • TOP CASES
  • Pfizer, Inc. v. Apotex, Inc., 480 F.3d 1348 (Fed. Cir. 2006)

05/22/2008 02:54:22 PM EST

Pfizer, Inc. v. Apotex, Inc., 480 F.3d 1348 (Fed. Cir. 2006)

Posted by

LexisNexis Patent Law Community Staff

A patented drug using amlodipine salt compounds was ruled invalid for obviousness, where the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art, under 35 U.S.C.S. § 103(a); a skilled artisan would have used a besylate salt.
 
Lexis.com subscribers can view the enhanced version of Pfizer, Inc. v. Apotex, Inc.
 
Non-subscribers can use lexisOne’s Free Case Law search to view the free, un-enhanced version of Pfizer, Inc. v. Apotex, Inc.

Add a Comment

(required)  
(optional)
(required)  
Enter the Image Code: